(MDBH) MDB Capital Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US55285N1090
MDBH EPS (Earnings per Share)
MDBH Revenue
MDBH: Investment, Brokerage, Intellectual Property, Synthetic Biology
MDB Capital Holdings, LLC is a multifaceted financial services company with a unique blend of traditional investment banking and cutting-edge technology development. Through its subsidiaries, the company operates as a broker-dealer, facilitating private and public securities offerings, and providing research services for investment banking due diligence. This core business is complemented by a Technology Development segment that focuses on synthetic biology research and development, a field with vast potential for innovation and growth.
The companys dual-segment approach allows it to diversify its revenue streams and capitalize on opportunities in both the financial services and biotech sectors. With its roots dating back to 1997, MDB Capital Holdings has established a presence in the industry, and its base in Addison, Texas, provides a strategic location for its operations. For more information, the companys website can be accessed at https://www.mdb.com.
Analyzing the available
Forecasting the stocks performance based on the available data, a potential buying opportunity may arise if the stock price continues to hover around the current levels, and the SMA20 indicator begins to trend upwards. A break above the SMA50 at $5.20 could signal a bullish reversal, potentially driving the stock price towards the SMA200 at $6.66. However, if the bearish trend persists, the stock may continue to experience downward pressure, potentially testing the 52-week low. A thorough analysis of the companys financials, industry trends, and overall market conditions would be necessary to make a more informed investment decision.
Additional Sources for MDBH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MDBH Stock Overview
Market Cap in USD | 45m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2023-09-21 |
MDBH Stock Ratings
Growth Rating | -56.5 |
Fundamental | 37.2 |
Dividend Rating | 0.0 |
Rel. Strength | -57.6 |
Analysts | - |
Fair Price Momentum | 3.00 USD |
Fair Price DCF | - |
MDBH Dividends
Currently no dividends paidMDBH Growth Ratios
Growth Correlation 3m | -85.9% |
Growth Correlation 12m | -86% |
Growth Correlation 5y | -91.1% |
CAGR 5y | -47.58% |
CAGR/Max DD 5y | -0.67 |
Sharpe Ratio 12m | -0.46 |
Alpha | -49.51 |
Beta | -0.377 |
Volatility | 70.71% |
Current Volume | 1.9k |
Average Volume 20d | 3.3k |
As of June 19, 2025, the stock is trading at USD 4.06 with a total of 1,895 shares traded.
Over the past week, the price has changed by +7.69%, over one month by -15.42%, over three months by -37.53% and over the past year by -47.61%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, MDB Capital Holdings (NASDAQ:MDBH) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.17 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDBH is around 3.00 USD . This means that MDBH is currently overvalued and has a potential downside of -26.11%.
MDB Capital Holdings has no consensus analysts rating.
According to our own proprietary Forecast Model, MDBH MDB Capital Holdings will be worth about 3.2 in June 2026. The stock is currently trading at 4.06. This means that the stock has a potential downside of -20.2%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 3.2 | -20.2% |